KK Shah Hospitals Ltd. benchmarking: Performance to industry peers

Financial

	KK Shah Hospitals	Transgene Biotek	Tejnaksh Healthcare
Operational Metrics
Financials
5 yr Average ROE	2.86 %	0.0	9.94 %
5yr average Equity Multiplier	1.1	11.14	1.37
5yr Average Asset Turnover Ratio	0.47	0.0	0.42
5yr Avg Net Profit Margin	5.16 %	-5919.21 %	17.13 %
Price to Book	0.0	2.61	1.09
P/E	0.0	0.0	21.05
5yr Avg Cash Conversion Cycle	3.41 Days	59.29 Days	-17.5 Days
Inventory Days	0.0	166.26 Days	21.42 Days
Days Receivable	3.41 Days	11.76 Days	33.57 Days
Days Payable	0.0	259.7 Days	123.99 Days
5yr Average Interest Coverage Ratio	-202.71	-19.2	6.73
5yr Avg ROCE	2.76 %	-3.86 %	12.42 %
5yr Avg Operating Profit Margin	9.16 %	-527.18 %	32.37 %
5 yr average Debt to Equity	0.0	1.02	0.23
5yr CAGR Net Profit	n/a	-42.08 %	2.59 %
5yr Average Return on Assets	2.0 %	-3.77 %	7.26 %
Shareholdings
Promoter Holding	71.36 %	23.64 %	73.83 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	KK Shah Hospitals	Transgene Biotek	Tejnaksh Healthcare
Product Wise Break-Up	Product Wise Break-Up Healthcare services 100.0 Other Operating Revenues 0 Pathology 0 Operation & Surgery 0 Consultation Fee 0 Traded Goods 0	Product Wise Break-Up Traded Goods 0 Pathology 0 Other Operating Revenues 0 Consultation Fee 0 Healthcare services 0 Operation & Surgery 0 Others 100	Product Wise Break-Up Traded Goods 15.67 Pathology 16.93 Other Operating Revenues 1.76 Consultation Fee 9.28 Healthcare services 0 Operation & Surgery 56.36
Location Wise Break-Up	Location Wise Break-Up India 0 Domestic 0 Others 100	-	Location Wise Break-Up India 100.0 India 0